Document Detail


Infliximab treatment in refractory Kawasaki syndrome.
MedLine Citation:
PMID:  18537019     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Kawasaki syndrome is one of the commonest vasculitides in pediatric age group with devastating consequences if not treated early. Intravenous Gammaglobulin leads to rapid amelioration of clinical symptoms and significantly decreases the risk of development of coronary artery aneurysms. Occasionally, Kawasaki disease may be resistant to I/V IgG. We present our experience with one such patient who ultimately respondend to infliximab therapy.
Authors:
Meenakshi Girish; Girish Subramaniam
Related Documents :
9248989 - Likely gains in life expectancy of patients with coronary artery disease treated with h...
1698369 - Soluble interleukin-2 receptors in children with kawasaki syndrome.
2795279 - The spectrum of coronary artery pathologic findings in human cardiac allografts.
10212169 - Effects of l- and d-arginine on the basal tone of human diseased coronary arteries and ...
4064109 - Can total coronary occlusions be predicted from a previous coronary arteriogram?
16122719 - Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility...
10948779 - Coronary mr angiography: current status.
24393449 - Left upper lobectomy can be a risk factor for thrombosis in the pulmonary vein stump.
15734769 - Comparison of synchrotron radiation angiography with conventional angiography for the d...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2008-06-08
Journal Detail:
Title:  Indian journal of pediatrics     Volume:  75     ISSN:  0973-7693     ISO Abbreviation:  Indian J Pediatr     Publication Date:  2008 May 
Date Detail:
Created Date:  2008-06-09     Completed Date:  2008-08-13     Revised Date:  2010-01-14    
Medline Journal Info:
Nlm Unique ID:  0417442     Medline TA:  Indian J Pediatr     Country:  India    
Other Details:
Languages:  eng     Pagination:  521-2     Citation Subset:  IM    
Affiliation:
Children's Hospital, Midas Heights, Nagpur, India. min_gir@rediffmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Inflammatory Agents / therapeutic use*
Antibodies, Monoclonal / therapeutic use*
Child, Preschool
Humans
Male
Mucocutaneous Lymph Node Syndrome / drug therapy*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Antibodies, Monoclonal; 0/infliximab
Comments/Corrections
Comment In:
Indian J Pediatr. 2009 Nov;76(11):1184; author reply 1184   [PMID:  20072867 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Semilobar holoprosencephaly in Seckel syndrome.
Next Document:  Round pneumonia in children.